Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EC Healthcare ( (HK:2138) ) has provided an announcement.
EC Healthcare has issued a profit warning for the fiscal year ending March 2025, anticipating a significant decrease in EBITDA to approximately HK$300-310 million from HK$388.1 million in the previous year. The company expects to report a loss attributable to equity holders between HK$170 million and HK$190 million, largely due to non-cash impairments and fair value losses. Despite these challenges, the company maintains a strong cash position of approximately HK$1,000 million, indicating resilience in its balance sheet. The announcement highlights the impact of weakened consumer sentiment on future cash flow expectations, though the impairments are non-cash and will not affect operational cash flow.
More about EC Healthcare
EC Healthcare operates in the healthcare industry, focusing on providing medical and healthcare services. The company is involved in various aspects of healthcare, including medical aesthetics, preventive healthcare, and other related services, primarily targeting the Hong Kong market.
Average Trading Volume: 389,216
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$746.7M
For detailed information about 2138 stock, go to TipRanks’ Stock Analysis page.